Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.12, 2012-12, pp. : 1789-1800

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-angiogenic drugs currently in Phase II clinical trials for gynecological cancer treatment

By Wei Xia-wei Zhang Zhi-rong Wei Yu-Quan

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. : 1181-1192

Informa Healthcare

Access to resources Recommend Favorite

Randomized Phase II Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

Therapies currently in Phase II trials for malignant pleural mesothelioma

By Pinton Giulia Manente Arcangela Gabriella Tavian Daniela Moro Laura Mutti Luciano

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1255-1263

Informa Healthcare

Access to resources Recommend Favorite

An update on bronchodilators in Phase I and II clinical trials

By Cazzola Mario Rogliani Paola Segreti Andrea Matera Maria Gabriella

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1489-1501

Informa Healthcare

Access to resources Recommend Favorite

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

Current Gene Therapy, Vol. 9, Iss. 5, 2009-01 ,pp. : 368-374

Bentham Science Publishers

Access to resources Recommend Favorite